Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

IPCA Laboratories Ltd

IPCALAB:NSI

IPCA Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,566.00
  • Today's Change-39.40 / -2.45%
  • Shares traded313.48k
  • 1 Year change+44.32%
  • Beta0.3687
Data delayed at least 15 minutes, as of Nov 26 2024 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Pharma Nigeria Ltd., Trophic Wellness Pvt. Ltd.

  • Revenue in INR (TTM)85.33bn
  • Net income in INR6.61bn
  • Incorporated1949
  • Employees17.34k
  • Location
    IPCA Laboratories Ltd125,Kandivli Industrial Estate, Kandivli (WeMUMBAI 400067IndiaIND
  • Phone+91 2 262105000
  • Fax+91 2 228686613
  • Websitehttps://www.ipca.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wockhardt Ltd29.49bn-2.88bn210.41bn2.39k--5.85--7.13-19.85-19.85201.29221.320.3931.874.1912,318,300.00-3.93-4.56-6.33-8.2959.1055.26-10.00-12.700.56770.2470.3869--5.55-4.7317.17---4.71--
Alembic Pharmaceuticals Ltd63.57bn6.47bn214.88bn14.86k33.254.4023.243.3832.8832.88323.14248.680.9290.93665.434,278,678.009.4510.7213.3214.2573.8465.9810.1712.470.805712.620.179128.2910.199.6280.071.05-15.5914.87
Concord Biotech Ltd10.86bn3.28bn215.70bn1.38k55.6613.5656.5119.8737.0437.04114.79152.020.6551.113.557,884,886.0019.78--21.82--76.00--30.20--4.83194.730.0022--19.20--28.33------
Pfizer Ltd22.38bn6.18bn240.58bn1.72k38.946.4135.4410.75135.06135.06489.19819.900.52881.8311.1613,004,360.0014.6014.2217.0517.7165.0061.3727.6124.054.3046.210.026782.67-9.551.05-11.645.1433.359.24
Natco Pharma Ltd.45.61bn19.45bn244.48bn4.02k12.573.4211.465.36108.58108.58254.65399.190.62910.89283.5711,356,080.0026.8212.3330.8514.2585.4773.0542.6325.164.19108.700.028318.9647.7213.8194.0916.59-4.7114.87
Emcure Pharmaceuticals Ltd72.56bn5.67bn248.11bn11.15k43.206.0225.833.4230.3730.37389.63217.790.9781.803.966,510,068.008.027.1413.5513.9361.1159.298.207.810.95495.250.21650.0011.237.14-6.3621.35-5.93--
J B Chemicals and Pharmaceuticals Ltd37.11bn6.11bn272.50bn5.31k45.638.4835.467.3438.4538.45233.33206.820.94812.594.856,987,882.0015.6115.7718.6218.8966.2661.1816.4716.062.2027.530.030333.0810.6316.2234.8423.3640.1537.42
Laurus Labs Ltd50.53bn1.31bn286.86bn6.01k218.696.9452.615.682.432.4393.7076.700.6021.183.068,412,186.001.5510.132.5216.4753.4447.632.5812.830.58181.810.402313.00-16.5517.07-79.6811.3621.6821.67
Gland Pharma Ltd58.90bn6.92bn292.26bn4.22k42.263.3327.184.9641.9841.98357.57533.410.55671.284.1113,967,630.006.5413.237.6514.5660.3055.5811.7422.923.1433.110.03587.2656.2922.61-1.1011.3224.02--
Suven Pharmaceuticals Ltd9.61bn2.43bn329.38bn1.05k135.6816.65108.5634.279.549.5437.7377.710.41561.525.999,136,501.0010.5023.1711.5026.2061.4258.8525.2733.214.0029.500.019118.63-21.5622.71-26.9922.41-1.83--
Piramal Pharma Ltd87.04bn453.30m330.35bn6.72k734.624.1841.063.800.34070.340766.3659.910.57991.404.8812,954,040.000.302--0.428--63.69--0.5208--0.56037.490.3771--15.39--109.56------
Ajanta Pharma Ltd44.91bn8.75bn374.32bn7.84k43.0910.1836.998.3469.5569.55356.94294.360.97381.334.165,725,128.0018.9716.6123.2920.4775.7773.2219.4819.312.1349.880.008831.2012.4515.4138.8116.10-14.9710.76
GlaxoSmithKline Pharmaceuticals Limited35.60bn6.75bn396.69bn3.21k59.1323.7253.3511.1439.6039.60209.3198.741.012.5914.8511,088,370.0019.2411.0136.0917.8861.7055.7718.9612.251.38554.800.0088192.076.212.00-2.915.78-36.029.86
IPCA Laboratories Ltd85.33bn6.61bn407.74bn17.34k61.656.0938.224.7826.0726.07336.37264.100.74831.124.784,922,642.005.8810.339.0013.5267.3659.167.8512.251.3225.330.12912.8623.3915.3516.134.2417.9021.67
Glenmark Pharmaceuticals Ltd122.48bn-10.18bn420.57bn14.99k--4.98--3.43-36.13-31.05434.11299.290.69511.534.048,171,082.00-5.641.02-8.511.4365.6459.47-8.111.431.002.560.174156.981.983.67-1,018.93---5.894.56
Abbott India Ltd60.66bn12.85bn589.84bn3.81k45.9116.7543.489.72604.57604.572,854.721,657.051.275.3215.7115,904,690.0026.8220.9236.9728.5945.0944.2021.1817.261.71131.360.016977.069.359.7226.5221.6831.0852.32
Data as of Nov 26 2024. Currency figures normalised to IPCA Laboratories Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

31.34%Per cent of shares held by top holders
HolderShares% Held
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 04 Sep 202422.93m9.04%
DSP Asset Managers Pvt. Ltd.as of 31 Oct 202414.72m5.80%
Kotak Mahindra Asset Management Co. Ltd.as of 02 Aug 202412.75m5.03%
SBI Life Insurance Co. Ltd. (Investment Portfolio)as of 31 Aug 20245.00m1.97%
The Vanguard Group, Inc.as of 06 Nov 20245.00m1.97%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Oct 20244.88m1.92%
HDFC Life Insurance Co. Ltd. (Investment Portfolio)as of 31 Oct 20244.71m1.86%
PPFAS Asset Management Private Ltd.as of 31 Oct 20243.72m1.47%
Kotak Mahindra Asset Management (Singapore) Pte Ltd.as of 30 Jun 20233.27m1.29%
Abu Dhabi Investment Authority (Investment Management)as of 30 Jun 20242.54m1.00%
More ▼
Data from 31 Jul 2024 - 21 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.